← Back to Search

Adult ACL Reconstruction Patients for Muscle Wasting

N/A
Waitlist Available
Led By Robert Westermann, MD
Research Sponsored by Robert Westermann
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Part 1 - Healthy Controls
Healthy adults with no known musculoskeletal injury
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial is testing whether musculoskeletal ultrasound is a reliable and valid tool for quadriceps size measurements in postoperative lower limb orthopedic patients.

Eligible Conditions
  • Proximal Muscle Atrophy
  • Muscle Wasting
  • Anterior Cruciate Ligament Tear
  • Quadriceps Atrophy

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Amount of quadriceps atrophy using musculoskeletal ultrasound following anterior cruciate ligament reconstruction
Reliability of musculoskeletal ultrasound use
Validity of musculoskeletal ultrasound use

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Adult ACL Reconstruction PatientsExperimental Treatment2 Interventions
Subjects included in part II of the study will be adult volunteers undergoing anterior cruciate ligament reconstruction at the University of Iowa. Exclusion criteria will be non-English speaking persons, women who are pregnant, patients undergoing multi-ligament repair, patients undergoing ACL reconstruction revision, patients undergoing concomitant cartilage or meniscal repair procedures, and patients undergoing bilateral ACL reconstructions.
Group II: Adult Healthy ControlsPlacebo Group2 Interventions
Subjects included in part I of this study will be healthy adult volunteers with no known musculoskeletal injury. Exclusion criteria will be those with identified musculoskeletal injury, non-English speaking persons, and women who are pregnant.

Find a Location

Who is running the clinical trial?

Robert WestermannLead Sponsor
Robert Westermann, MDPrincipal InvestigatorUniversity of Iowa

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Mar 2025